Immunotoxicity of Perfluorinated Compounds: Recent Developments
暂无分享,去创建一个
J. M. Keller | J. DeWitt | D. Germolec | M. Peden‐Adams | Jamie C. DeWitt | Dori R. Germolec | Margie M. Peden-Adams | Jennifer M. Keller
[1] Paul D. Jones,et al. Accumulation of perfluorooctane sulfonate in marine mammals. , 2001, Environmental science & technology.
[2] Yi-he Jin,et al. Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice , 2011, Archives of Toxicology.
[3] Jeffrey H Mandel,et al. Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations , 2003, Journal of occupational and environmental medicine.
[4] G. Jiang,et al. Modulation of dietary fat on the toxicological effects in thymus and spleen in BALB/c mice exposed to perfluorooctane sulfonate. , 2011, Toxicology letters.
[5] A. Calafat,et al. Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. , 2004, Environmental science & technology.
[6] Mark J. Strynar,et al. Perfluorooctanoic Acid–Induced Immunomodulation in Adult C57BL/6J or C57BL/6N Female Mice , 2008, Environmental health perspectives.
[7] Yi-he Jin,et al. Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice , 2009, Archives of Toxicology.
[8] Marina Marinovich,et al. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). , 2011, Toxicology and applied pharmacology.
[9] Qian Yang,et al. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. , 2002, International immunopharmacology.
[10] J. M. Keller,et al. Temporal and spatial trends of perfluorinated compounds in juvenile loggerhead sea turtles (Caretta caretta) along the East Coast of the United States. , 2010, Environmental science & technology.
[11] J. Depierre,et al. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. , 2009, Toxicology.
[12] N Yamashita,et al. Perfluorinated compounds in some terrestrial and aquatic wildlife species from Poland , 2007, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.
[13] C. Glass,et al. WY14,643, a PPARα Ligand, Has Profound Effects on Immune Responses In Vivo1 , 2002, The Journal of Immunology.
[14] Thomas Griesbacher,et al. Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis. , 2008, International immunopharmacology.
[15] Melvin E Andersen,et al. Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[16] M. Peden‐Adams,et al. Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice , 2011, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.
[17] R. Luebke,et al. Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[18] Nobuyoshi Yamashita,et al. Fluorinated alkyl compounds including long chain carboxylic acids in wild bird livers from Japan. , 2011, Chemosphere.
[19] C. Lau,et al. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. , 2009, Reproductive toxicology.
[20] Kurunthachalam Kannan,et al. Association between perfluorinated compounds and pathological conditions in southern sea otters. , 2006, Environmental science & technology.
[21] F. Burleson,et al. Testing Human Biologicals in Animal Host Resistance Models , 2008, Journal of immunotoxicology.
[22] Steve E. Calvano,et al. Acute Inflammatory Response to Endotoxin in Mice and Humans , 2005, Clinical Diagnostic Laboratory Immunology.
[23] L. Luttrell,et al. Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. , 2007, Molecular immunology.
[24] C. Wilson,et al. Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens. , 1999, Journal of immunology.
[25] J. Depierre,et al. Effects of peroxisome proliferators on the thymus and spleen of mice , 2000, Clinical and experimental immunology.
[26] J. M. Keller,et al. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[27] Kyle Steenland,et al. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. , 2009, American journal of epidemiology.
[28] H. Haase,et al. Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[29] G. Bossard. Marine Mammals as Sentinel Species for Oceans and Human Health , 2006 .
[30] M. A. Mohd,et al. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. , 2004, Environmental science & technology.
[31] D. Keil,et al. Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice , 2011, Journal of immunotoxicology.
[32] Shinsuke Tanabe,et al. Perfluorooctanesulfonate and related fluorochemicals in albatrosses, elephant seals, penguins, and polar skuas from the Southern Ocean. , 2006, Environmental science & technology.
[33] S. Hopkins. Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration. , 2007, Acta bio-medica : Atenei Parmensis.
[34] T. Scott,et al. Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS). , 2009, Reproductive toxicology.
[35] J. M. Keller,et al. Effects of Organochlorine Contaminants on Loggerhead Sea Turtle Immunity: Comparison of a Correlative Field Study and In Vitro Exposure Experiments , 2005, Environmental health perspectives.
[36] R. Blust,et al. Evaluation of the toxicological effects of perfluorooctane sulfonic acid in the common carp (Cyprinus carpio). , 2003, Aquatic toxicology.
[37] C. Vinson,et al. CD40-Mediated Transcriptional Regulation of the IL-6 Gene in B Lymphocytes: Involvement of NF-κB, AP-1, and C/EBP1 , 2003, The Journal of Immunology.
[38] R. Mehta,et al. Immunomodulatory Effects of Dietary Potassium Perfluorooctane Sulfonate (PFOS) Exposure in Adult Sprague-Dawley Rats , 2008, Journal of toxicology and environmental health. Part A.
[39] John P Giesy,et al. Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas. , 2002, Environmental science & technology.
[40] Sang-Hyun Kim,et al. Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice , 2009, Environmental toxicology.
[41] Derek C G Muir,et al. Polyfluoroalkyl compounds in free-ranging bottlenose dolphins (Tursiops truncatus) from the Gulf of Mexico and the Atlantic Ocean. , 2005, Environmental science & technology.
[42] G. Charnley,et al. A Margin-of-Exposure Approach to Assessment of Noncancer Risks of Dioxins Based on Human Exposure and Response Data , 2008, Environmental health perspectives.
[43] D. Keil,et al. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[44] R. Clark. The role of PPARs in inflammation and immunity , 2002, Journal of leukocyte biology.
[45] Ronny Blust,et al. High accumulation of perfluorooctane sulfonate (PFOS) in marine tucuxi dolphins (Sotalia guianensis) from the Brazilian coast. , 2008, Environmental science & technology.
[46] L. Birnbaumer,et al. Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in splenocytes by Gαi proteins , 2006 .
[47] John P Giesy,et al. Perfluorooctanesulfonate and related fluorinated hydrocarbons in mink and river otters from the United States. , 2002, Environmental science & technology.
[48] J. Moreau,et al. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients , 2003, Immunology.
[49] Nobuyoshi Yamashita,et al. A survey of perfluorooctane sulfonate and related perfluorinated organic compounds in water, fish, birds, and humans from Japan. , 2003, Environmental science & technology.
[50] T. Fletcher,et al. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. , 2011, Environmental research.
[51] R. Luebke,et al. Immunotoxicity of Perfluorooctanoic Acid and Perfluorooctane Sulfonate and the Role of Peroxisome Proliferator-Activated Receptor Alpha , 2009, Critical reviews in toxicology.
[52] S. Anderson,et al. Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[53] Qiang Yang,et al. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. , 2001, Biochemical pharmacology.
[54] Yi-he Jin,et al. Subchronic effects of perfluorooctanesulfonate exposure on inflammation in adult male C57BL/6 mice , 2012, Environmental toxicology.
[55] D. Consonni,et al. Thirty Years of Medical Surveillance in Perfluooctanoic Acid Production Workers , 2009, Journal of occupational and environmental medicine.
[56] K. Andolsek,et al. Risk assessment , 2003, Nature.
[57] C. Gennings,et al. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[58] B. Taylor,et al. Peroxisome Proliferator-Activated Receptor Agonists Inhibit Inflammatory Edema and Hyperalgesia , 2002, Inflammation.
[59] Yong Zhao,et al. Immunotoxic effects of perfluorononanoic acid on BALB/c mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[60] J. M. Keller,et al. Perfluorinated compounds in the plasma of loggerhead and Kemp's ridley sea turtles from the southeastern coast of the United States. , 2005, Environmental science & technology.
[61] J. Giesy,et al. Perfluorinated Compounds in Aquatic Organisms at Various Trophic Levels in a Great Lakes Food Chain , 2005, Archives of environmental contamination and toxicology.
[62] Frank J. Gonzalez,et al. Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1* , 1999, The Journal of Biological Chemistry.
[63] K. Lowe,et al. Lymphoid tissue responses to emulsified perfluorochemicals: comparative aspects. , 1988, Biomaterials, artificial cells, and artificial organs.
[64] D. Savitz,et al. Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA) , 2010, Environmental health perspectives.
[65] Kurunthachalam Kannan,et al. Perfluorinated contaminants in sediments and aquatic organisms collected from shallow water and tidal flat areas of the Ariake Sea, Japan: environmental fate of perfluorooctane sulfonate in aquatic ecosystems. , 2006, Environmental science & technology.
[66] R. Dietz,et al. Preliminary screening of perfluorooctane sulfonate (PFOS) and other fluorochemicals in fish, birds and marine mammals from Greenland and the Faroe Islands. , 2005, Environmental pollution.
[67] C. Lau,et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[68] D. Keil,et al. Suppression of Humoral Immunity Following Exposure to the Perfluorinated Insecticide Sulfluramid , 2007, Journal of toxicology and environmental health. Part A.
[69] S. Biswal,et al. Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886 , 2001 .
[70] R. Luebke,et al. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. , 2009, Critical reviews in toxicology.
[71] K. Kannan,et al. Perfluorinated compounds in minke whales (Balaenoptera acutorostrata) and long-beaked common dolphins (Delphinus capensis) from Korean coastal waters. , 2010, Marine pollution bulletin.
[72] J. DeWitt,et al. Are developmentally exposed C57BL/6 mice insensitive to suppression of TDAR by PFOA? , 2010, Journal of immunotoxicology.
[73] B. Taylor,et al. Central administration of perfluorooctanoic acid inhibits cutaneous inflammation , 2005, Inflammation Research.
[74] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[75] L. Shaw,et al. Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters , 2006, Journal of occupational and environmental medicine.
[76] P. Keipert,et al. Randomized Safety Studies of Intravenous Perflubron Emulsion. II. Effects on Immune Function in Healthy Volunteers , 2000 .
[77] Yi-he Jin,et al. Type 1 and Type 2 cytokines imbalance in adult male C57BL/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS) , 2011, Journal of immunotoxicology.
[78] Marcel Eens,et al. PFOS levels in the blood and liver of a small insectivorous songbird near a fluorochemical plant. , 2007, Environment international.
[79] Jeffrey H Mandel,et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.
[80] Yi-he Jin,et al. Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice , 2009, Archives of Toxicology.
[81] Scott A Mabury,et al. Identification of long-chain perfluorinated acids in biota from the Canadian Arctic. , 2004, Environmental science & technology.
[82] Yimin,et al. A Regulatory Effect of the Balance between TNF-α and IL-6 in the Granulomatous and Inflammatory Response to Rhodococcus aurantiacus Infection in Mice1 , 2006, The Journal of Immunology.
[83] Jiayin Dai,et al. Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[84] J. Depierre,et al. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). , 2009, Toxicology.
[85] J. M. Keller,et al. Health effects of perfluorinated compounds—What are the wildlife telling us? , 2009 .
[86] N. Yamashita,et al. Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. , 2009, The Journal of toxicological sciences.
[87] John W. Froehlich,et al. Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.
[88] B. Spiess. The Physiology and Pathophysiology of the Hyperbaric and Diving Environments Perfluorocarbon emulsions as a promising technology : a review of tissue and vascular gas dynamics , 2009 .
[89] C. Lau,et al. Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[90] J. M. Keller,et al. Immunotoxicology and Implications for Reptilian Health , 2005 .
[91] D. H. Ramdhan,et al. Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha. , 2009, Toxicology.
[92] P. Keipert,et al. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. , 2000, Anesthesia and analgesia.
[93] J. Gimble,et al. Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia , 1999, Infection and Immunity.
[94] G. Bishop,et al. The CD40-CD154 interaction in B cell-T cell liaisons. , 2003, Cytokine & growth factor reviews.
[95] J. Giesy,et al. Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.